Icare Finland Oy, a subsidiary of Revenio Group, has signed an agreement to acquire the AI software company Thirona Retina, according to a press release.
The 4.8 million euro acquisition is an extension of Icare’s 1.9 million euro minority investment in Thirona Retina in 2023.
RetCAD, Thirona Retina’s AI technology, screens fundus images for ocular diseases such as diabetic retinopathy, glaucoma and age-related macular degeneration. The technology is integrated into the iCare Illume retinal screening solution, according to the release.
Revenio said the acquisition is part of its